1. Home
  2. IMNN vs YQ Comparison

IMNN vs YQ Comparison

Compare IMNN & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • YQ
  • Stock Information
  • Founded
  • IMNN 1982
  • YQ 2012
  • Country
  • IMNN United States
  • YQ China
  • Employees
  • IMNN N/A
  • YQ N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • YQ Other Consumer Services
  • Sector
  • IMNN Health Care
  • YQ Real Estate
  • Exchange
  • IMNN Nasdaq
  • YQ Nasdaq
  • Market Cap
  • IMNN 12.1M
  • YQ 19.4M
  • IPO Year
  • IMNN 1985
  • YQ 2020
  • Fundamental
  • Price
  • IMNN $5.04
  • YQ $3.55
  • Analyst Decision
  • IMNN Buy
  • YQ
  • Analyst Count
  • IMNN 2
  • YQ 0
  • Target Price
  • IMNN $182.61
  • YQ N/A
  • AVG Volume (30 Days)
  • IMNN 55.1K
  • YQ 27.8K
  • Earning Date
  • IMNN 11-06-2025
  • YQ 09-03-2025
  • Dividend Yield
  • IMNN N/A
  • YQ N/A
  • EPS Growth
  • IMNN N/A
  • YQ N/A
  • EPS
  • IMNN N/A
  • YQ N/A
  • Revenue
  • IMNN N/A
  • YQ $20,003,071.00
  • Revenue This Year
  • IMNN N/A
  • YQ N/A
  • Revenue Next Year
  • IMNN N/A
  • YQ N/A
  • P/E Ratio
  • IMNN N/A
  • YQ N/A
  • Revenue Growth
  • IMNN N/A
  • YQ N/A
  • 52 Week Low
  • IMNN $4.83
  • YQ $1.26
  • 52 Week High
  • IMNN $41.22
  • YQ $3.52
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 27.77
  • YQ 84.25
  • Support Level
  • IMNN $5.53
  • YQ $2.10
  • Resistance Level
  • IMNN $5.85
  • YQ $2.81
  • Average True Range (ATR)
  • IMNN 0.32
  • YQ 0.23
  • MACD
  • IMNN 0.02
  • YQ 0.13
  • Stochastic Oscillator
  • IMNN 4.57
  • YQ 100.00

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is an education technology company in China. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.

Share on Social Networks: